In agreement with our data, PIP has been reported to inhibit the PI3K/AKT axis in human triple-negative breast cancer cells [56] and to activate FOXO3, inducing the expression of the FOXO target gene BCL2 Like 11 (BIM) in HeLa cells [57]. This evidence concerns the gene AKT1 and triple-negative breast carcinoma.